Weave munications(US:WEAV)2026-02-19 22:32Financial Data and Key Metrics Changes - In Q4, the company achieved $63.4 million in total revenue, reflecting a 17% year-over-year growth, with gross margin reaching a record 73.3% [20][24] - Operating income for Q4 was $2.3 million, marking an improvement of over $500,000 compared to Q4 2024, resulting in an operating margin of 3.6% [23][30] - For the full year 2025, total revenue grew 17% to $239 million, with gross margin expanding to 72.7%, up 80 basis points from the previous year [30] Business Line Data and Key Metrics Changes - Weave Payments grew at more than twice the rate of total revenue in 2025, driven by new capabilities like automated payment reminders and bulk collections [16] - The specialty medical vertical became the second-largest vertical by location count, with significant growth in Q4 [16] Market Data and Key Metrics Changes - The company is in fewer than 15% of U.S. dental locations, indicating substantial growth potential in the dental market [19] - Specialty medical, which currently holds about 1% market share, is expected to be a significant growth area due to the introduction of AI-powered solutions [20] Company Strategy and Development Direction - The company aims to enhance patient experiences through a unified platform that reduces administrative burdens for healthcare professionals [5][6] - The acquisition of TrueLark is seen as a foundational step in expanding AI Receptionist capabilities, addressing staffing challenges in practices [13][19] - The company plans to roll out an omnichannel AI Receptionist in 2026, which will allow practices to manage patient interactions across various channels [14][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of revenue growth and margin expansion, emphasizing the importance of AI in enhancing operational efficiency [17][30] - The company anticipates continued strong growth in specialty medical and mid-market sectors, supported by recent investments in sales and marketing [22][31] Other Important Information - The company ended Q4 with $81.7 million in cash and short-term investments, reflecting strong liquidity [23] - The net revenue retention rate in Q4 was 93%, with gross revenue retention at 89%, indicating strong customer retention despite some challenges in newer verticals [24][28] Q&A Session Summary Question: Can you elaborate on the CareCredit integration? - The CareCredit partnership opens new avenues for capturing volumes that would otherwise flow through CareCredit, enhancing the payment solution's attractiveness [35][36] Question: What are your expectations for growth rates across different subverticals in 2026? - Management anticipates strong growth across specialty medical and mid-market sectors, with specialty medical expected to lead due to recent marketing efforts [37][38] Question: How do you plan to monetize the new AI capabilities? - The company is exploring whether to price new functionalities as additional modules or include them in existing bundles, confident in the ability to monetize the AI omnichannel receptionist [42][43] Question: Have churn rates stabilized in specialty medical cohorts? - Churn rates have shown improvement in Q4, returning to historical levels, with ongoing integrations expected to further enhance retention [44][45] Question: What are the investment priorities for the coming year? - Investment priorities include product and engineering, particularly in enhancing AI capabilities, as well as adjustments to the go-to-market strategy for efficiency [52][54] Question: How does Weave differentiate its AI capabilities from competitors? - Weave's unique advantages include ownership of the telephony stack, deep industry-specific workflows, and the ability to retain context across various patient interactions [56][58]